TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Scandinavian ChemoTech AB
Closing information (x1000 DKK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
1,895
|
316
|
36 |
Financial expenses |
942
|
1,268
|
491 |
Earnings before taxes |
-14,166
|
-15,200
|
-12,901 |
EBITDA |
-11,793
|
-12,004
|
-10,370 |
Total assets |
9,987
|
14,501
|
18,767 |
Current assets |
4,835
|
7,897
|
9,770 |
Current liabilities |
2,578
|
5,151
|
1,376 |
Equity capital |
7,409
|
9,350
|
17,391 |
- share capital |
6,024
|
4,014
|
3,501 |
Employees (average) |
6
![]() |
6
|
7 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
74.2%
|
64.5%
|
92.7% |
Turnover per employee |
316
|
53
|
5 |
Profit as a percentage of turnover |
-747.5%
|
-4810.1%
|
-35836.1% |
Return on assets (ROA) |
-132.4%
|
-96.1%
|
-66.1% |
Current ratio |
187.5%
|
153.3%
|
710.0% |
Return on equity (ROE) |
-191.2%
|
-162.6%
|
-74.2% |
Change turnover |
1,578
|
283
|
-60 |
Change turnover % |
497%
|
865%
|
-63% |
Chg. No. of employees |
0
|
-1
|
0 |
Chg. No. of employees % |
0%
|
-14%
|
0% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.